| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cawood Frank Wayne | 8.4% | $3,384,513 | 3,384,513 | Frank W. Cawood | 31 Dec 2024 |
As of 31 Dec 2025, 12 institutional investors reported holding 6,481,352 shares of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS). This represents 16% of the company’s total 40,291,821 outstanding shares.
The largest institutional shareholders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| M&G PLC | 13% | 5,197,349 | 0% | 0.03% | $5,197,349 |
| DC Funds, LP | 1.6% | 642,204 | 0% | 31% | $449,607 |
| RENAISSANCE TECHNOLOGIES LLC | 0.36% | 143,100 | +116% | 0% | $100,184 |
| Johns Hopkins University | 0.3% | 122,237 | 0% | 0.01% | $85,566 |
| CITADEL ADVISORS LLC | 0.29% | 118,799 | 0% | $83,171 | |
| Baird Financial Group, Inc. | 0.26% | 105,961 | -1.4% | 0% | $74,183 |
| Rangeley Capital, LLC | 0.21% | 84,441 | 0.05% | $59,117 | |
| HighTower Advisors, LLC | 0.09% | 37,450 | 0% | 0% | $26,219 |
| RHUMBLINE ADVISERS | 0.03% | 11,685 | 0% | $8,179 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.03% | 11,568 | 0% | 0% | $8,098 |
| MORGAN STANLEY | 0.01% | 3,406 | -31% | 0% | $2,385 |
| UBS Group AG | 0.01% | 3,152 | +24146% | 0% | $2,206 |
| Janney Montgomery Scott LLC | 0% | 0 | -100% | $0 | |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| SBI Securities Co., Ltd. | 0% | 0 | -100% | $0 | |
| HRT FINANCIAL LP | 0% | 0 | -100% | $0 | |
| Alphabet Inc. | 0% | 0 | -100% | $0 | |
| HSG Holding Ltd | 3.5% | 1,420,473 | 0% | $42,216,458 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 6,481,352 | $6,096,264 | -$1,748,009 | $0.70 | 12 |
| 2025 Q3 | 9,172,174 | $10,350,135 | -$134,698 | $1.25 | 15 |
| 2025 Q2 | 9,309,661 | $9,021,053 | -$163,257 | $0.93 | 14 |
| 2025 Q1 | 9,485,402 | $9,148,082 | -$234,186 | $0.97 | 14 |
| 2024 Q4 | 9,717,331 | $10,336,336 | -$702,886 | $1.21 | 16 |
| 2024 Q3 | 9,686,533 | $10,740,001 | -$279,458 | $1.19 | 19 |
| 2024 Q2 | 9,914,647 | $11,759,119 | +$303,322 | $1.40 | 18 |
| 2024 Q1 | 9,698,209 | $21,348,890 | -$47,421 | $2.38 | 15 |
| 2023 Q4 | 9,718,135 | $36,531,700 | +$41,711 | $3.69 | 15 |
| 2023 Q3 | 9,706,658 | $29,525,600 | -$281,231 | $3.09 | 16 |
| 2023 Q2 | 9,847,143 | $19,972,820 | -$752,585 | $2.06 | 15 |
| 2023 Q1 | 10,208,776 | $21,620,956 | -$48,614 | $2.24 | 13 |
| 2022 Q4 | 10,228,507 | $22,244,733 | +$312,161 | $2.35 | 15 |
| 2022 Q3 | 10,095,963 | $31,249,000 | +$10,999,294 | $3.20 | 11 |
| 2022 Q2 | 6,298,127 | $27,536,000 | +$7,434,957 | $4.45 | 12 |
| 2022 Q1 | 4,627,371 | $23,843,000 | -$1,912,073 | $5.20 | 10 |
| 2021 Q4 | 4,901,592 | $54,334,000 | -$2,208,184 | $11.11 | 14 |
| 2021 Q3 | 4,927,049 | $67,494,108 | -$4,976,210 | $15.74 | 15 |
| 2021 Q2 | 3,987,438 | $66,015,000 | +$66,015,000 | $16.78 | 18 |